Details for Patent: 5,990,100
✉ Email this page to a colleague
Summary for Patent: 5,990,100
Title: | Composition and method for treatment of psoriasis |
Abstract: | Pharmaceutical compositions and methods for use in the treatment of psoriasis, having isopropyl myristate as a first active ingredient and a different anti-psoriatic agent as a second active ingredient; preferably they are combined in the same pharmaceutical composition. |
Inventor(s): | Rosenberg; E. William (Memphis, TN), Glenn; Thomas M. (Mobile, AL), Skinner, Jr.; Robert B. (Memphis, TN), Noah; Patricia W. (Germantown, TN) |
Assignee: | Panda Pharmaceuticals, L.L.C. (Memphis, TN) The University of Tennessee Research Corporation (Knoxville, TN) |
Application Number: | 09/143,146 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 5,990,100
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |